Literature DB >> 21874058

Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib.

L-M Poon, L P Koh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874058     DOI: 10.1038/bmt.2011.176

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

Review 1.  Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review.

Authors:  Yazan Migdady; Asiri Ediriwickrema; Ryan Patrick Jackson; Wendy Kadi; Ridhi Gupta; Francisco Socola; Sally Arai; Beth A Martin
Journal:  Blood Adv       Date:  2020-03-10

Review 2.  Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.

Authors:  Javier Marco-Ayala; Inés Gómez-Seguí; Guillermo Sanz; Pilar Solves
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

3.  Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Thiti Asawapanumas; Chantiya Chanswangphuwana; Phandee Watanaboonyongcharoen; Ponlapat Rojnuckarin; Udomsak Bunworasate
Journal:  Leuk Res Rep       Date:  2022-04-13

4.  Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation.

Authors:  F Khan; M A Linden; N D Zantek; G M Vercellotti
Journal:  Transfus Med       Date:  2014-05-09       Impact factor: 2.019

5.  Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.

Authors:  Fleur M Aung; Benjamin Lichtiger; Roland Bassett; Ping Liu; Amin Alousi; Qaiser Bashier; Stefan O Ciurea; Marcos J de Lima; Chitra Hosing; Partow Kebriaei; Yago Nieto; Betul Oran; Simrit Parmar; Muzaffar Qazilbash; Nina Shah; Issa Khouri; Richard E Champlin; Uday Popat
Journal:  Br J Haematol       Date:  2013-01-18       Impact factor: 6.998

Review 6.  Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.

Authors:  Sakura Hosoba; David L Jaye; Cynthia Cohen; John D Roback; Edmund K Waller
Journal:  Transfusion       Date:  2014-08-25       Impact factor: 3.157

Review 7.  Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics.

Authors:  Yazan Migdady; Yifan Pang; Shelley S Kalsi; Richard Childs; Sally Arai
Journal:  Blood Adv       Date:  2022-04-26

8.  Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.

Authors:  Wilma Barcellini; Bruno Fattizzo; Anna Zaninoni
Journal:  J Blood Med       Date:  2019-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.